SCHEMBL3650863

SCHEMBL3650863

CCCCN=C(N)N1CCN(C(=O)C(O)(c2ccccc2)C2CCCC2)CC1

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CHRM3 P20309 20/20 0.61
▸ CHRM2 P08172 3/20 0.59
▸ CHRM1 P11229 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2001211 1.00 CHRM3 (0.61) CHRM3CHRM2CHRM1
SCHEMBL2001581 0.97 CHRM3 (0.60) CHRM3CHRM2CHRM1
SCHEMBL2002559 0.96 CHRM3 (0.59) CHRM3CHRM2CHRM1
SCHEMBL2001882 0.86 CHRM3 (0.68) CHRM3CHRM2CHRM1
SCHEMBL3652795 0.84 CHRM3 (0.64) CHRM3CHRM2CHRM1
SCHEMBL1998410 0.84 CHRM3 (0.66) CHRM3CHRM2CHRM1
SCHEMBL1997752 0.84 CHRM3 (0.64) CHRM3CHRM2CHRM1
SCHEMBL2002810 0.83 CHRM3 (0.65) CHRM3CHRM2CHRM1
SCHEMBL1998679 0.83 CHRM3 (0.65) CHRM3CHRM2CHRM1
SCHEMBL1997223 0.82 CHRM3 (0.59) CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2197841-A2 GUANIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2010-06-23 — — EP disclosed
WO-2009035542-A2 GUANIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2009-03-19 — — WO disclosed
Send feedback